SCHEMBL7207736

SCHEMBL7207736

ClCCn1cnc2ccccc21

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.78
▸ LMNA P02545 8/20 0.64
▸ SMN1; SMN2 Q16637 6/20 0.64
▸ HTT P42858 4/20 0.64
▸ CYP11B1 P15538 4/20 0.62
▸ CYP11B2 P19099 4/20 0.62
▸ TNF P01375 1/20 0.62
▸ EGLN3 Q9H6Z9 1/20 0.60
▸ L3MBTL1 Q9Y468 1/20 0.60
▸ RAB9A P51151 3/20 0.58
▸ GAA P10253 1/20 0.58
▸ MAPK1 P28482 1/20 0.57
▸ TSHR P16473 2/20 0.57
▸ NPSR1 Q6W5P4 1/20 0.57
▸ ALOX15 P16050 1/20 0.57
▸ PKM P14618 2/20 0.53
▸ NPC1 O15118 2/20 0.53
▸ MAPT P10636 1/20 0.53
▸ NFKB1 P19838 1/20 0.53
▸ NFKB2 Q00653 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5637113 0.91 TDP1 (0.75) TDP1LMNASMN1; SMN2HTTCYP11B1
SCHEMBL9995334 0.89 TDP1 (0.72) TDP1LMNASMN1; SMN2HTTCYP11B1
SCHEMBL6442808 0.88 TDP1 (1.00) TDP1LMNASMN1; SMN2HTTCYP11B1
SCHEMBL30814332 0.87 TDP1 (0.70) TDP1LMNASMN1; SMN2HTTCYP11B1
SCHEMBL29162973 0.87 TDP1 (0.70) TDP1LMNASMN1; SMN2HTTCYP11B1
SCHEMBL131657 0.84 TDP1 (0.70) TDP1LMNASMN1; SMN2HTTCYP11B1
SCHEMBL30294105 0.84 TDP1 (0.84) TDP1LMNASMN1; SMN2HTTCYP11B1
SCHEMBL9814242 0.84 TDP1 (0.84) TDP1LMNASMN1; SMN2HTTCYP11B1
SCHEMBL3161153 0.84 TDP1 (0.84) TDP1LMNASMN1; SMN2HTTCYP11B1
SCHEMBL352046 0.82 TDP1 (0.81) TDP1LMNASMN1; SMN2HTTCYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313751-A1 NEW MACROLIDES WITH ANTIBACTERIAL ACTIVITY Basilea Pharmaceutica AG (CH) 2003-05-28 — — EP disclosed
WO-2002016380-A1 NEW MACROLIDES WITH ANTIBACTERIAL ACTIVITY BASILEA PHARMACEUTICA AG (CH) 2002-02-28 — — WO disclosed
EP-0728752-A1 Triazole compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-08-28 — — EP disclosed
EP-0393574-B1 Hexitol derivatives KYOWA HAKKO KOGYO KK (JP) 1996-01-31 — — EP disclosed
US-5405861-A Fungicides TAKEDA CHEMICAL INDUSTRIES, CO., LTD. (JP) 1995-04-11 — — US disclosed
US-RE34201-E Analgesics ANAQUEST, INC. (US) 1993-03-23 — — US disclosed
EP-0276942-B1 6-BETA(SUBSTITUTED)-(S)-HYDROXYMETHYLPENICILLANIC ACIDS AND DERIVATIVES THEREOF PFIZER INC. (US) 1992-04-01 — — EP disclosed
US-5053408-A Cardiovascular disorders KYOWA HAKKO KOGYO CO., LTD. (JP) 1991-10-01 — — US disclosed
US-5053411-A Analgesics ANAQUEST, INC. (US) 1991-10-01 — — US disclosed
EP-0421210-A2 Triazole compounds, their production and use Takeda Chemical Industries, Ltd. (JP) 1991-04-10 — — EP disclosed
EP-0396282-A2 N-aryl-N-[4-(heterocyclicalkyl) piperidinyl]amides and pharmaceutical compositions and methods employing such compounds BOC, INC. (US) 1990-11-07 — — EP disclosed
EP-0393574-A2 Hexitol derivatives KYOWA HAKKO KOGYO CO., LTD. (JP) 1990-10-24 — — EP disclosed
US-4782050-A BACTERICIDES PFIZER INC. (US) 1988-11-01 — — US disclosed
EP-0276942-A1 6-Beta(substituted)-(S)-hydroxymethylpenicillanic acids and derivatives thereof PFIZER INC. (US) 1988-08-03 — — EP disclosed
Send feedback